Explore tweets tagged as #Linzagolix
Big news! NHS England just approved Linzagolix – a new daily pill for endometriosis. This means vital relief from painful periods and pelvic pain for over 1,000 women yearly. For the 1 in 10 women affected, it's welcome relief. A win for better care and awareness. Thoughts? 💭
0
0
0
Reduced heavy menstrual bleeding was sustained with #linzagolix therapy, regardless of adjunct hormonal add-back therapy, at 1 year among patients with #UterineFibroids.
0
0
0
Did you know? Linzagolix with hormonal add-back therapy can be used within its marketing authorisation as an option to treat symptoms of endometriosis in adults of reproductive age who have had medical/surgical treatment for their endometriosis. See more:
0
1
0
📢 Discover the next symposium with Theramex on "Overcoming Challenges in Uterine Fibroids: A Spotlight on Linzagolix" on April 25th at 13:15!. Join Marie-Madeleine Dolmans, Felice Petraglia, Mariona Rius and Francois Closon to explore the challenges of uterine fibroid management
0
0
0
Get ready for the 1st #SEUD2024 Lunch Symposium with Theramex on « Linzagolix – a flexible treatment option for women with uterine fibroids » thanks to our international experts!. Save your seat ➡ #endometriosis #gynecology #adenomyosis #uterinedisorders
0
0
2
Kissei Pharmaceutical sees 5% sales growth in Q1FY26 despite price revision and competition. The company has revised FY26 guidance down due to in-licensing agreement anticipation.
0
0
0
European Commission approves Yselty (linzagolix) for the symptomatic treatment of endometriosis - Theramex
0
0
2
#Linzagolix with and without concomitant add-back therapy vs placebo was associated with reduced heavy #menstrual bleeding among patients with uterine fibroids.
0
0
0
#Linzagolix 100 -200 mg with-without #addbacktherapy significnt redced heavy #menstrualbleeding. Partial suppression with onceperday linzago 100 without add-back potentially provides a option for the chronic #treatment of symptomatic #uterinefibroids .
0
0
3
Эндометрозын эмийг өдөр бүр ууж болно- Британы NICE эмчилгээний удирдамж ба технологийн үнэлгээ хийдэг байгууллага linzagolix гэх Yselty компаны эмийг өдөр бүр ууж болно гэж зөвлөжээ . Эндометрозын асуудал тус улсын сая гаран эмэгтэйчүүдэд тулгардаг гэнэ.
0
0
0
New at-home tablet for endometriosis: we've recommended linzagolix with hormonal add-back therapy. This is likely to benefit up to 1,000 women per year on the NHS, reducing the need for hospital treatments and giving patients more control. Learn more🔎
2
3
5
Endometriosis: daily pill to manage pain and symptoms will soon be available on the NHS – here’s how linzagolix works Endometriosis affects one in ten women of reproductive age. The condition causes the lining of the womb (the endometrium) to grow outside.
0
0
0
Significant improvements in #dyschezia and overall #pelvicpain were observed in both #linzagolix groups when compared to #placebo. Small improvements in #dyspareunia scores were observed in both groups but they were #notsignificant.
0
1
1
Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with endometriosis.
0
0
0
The National Institute for Health and Care Excellence has recommended linzagolix (marketed as Yselty) for moderate to severe symptoms of uterine fibroids, an option that could benefit up to 30 000 adults in England and Wales.
0
3
3
Second take-at-home pill for endometriosis 👉🩺 approved for NHS use . #Linzagolix . 1.5 million women in the UK - it can cause chronic pain, heavy periods and extreme tiredness. @Michell24423236 @DrPriyaDas1 @me3_shh
0
0
2
♀️ In a boost for women’s health, the National Institute for #Health and Care Excellence has recommended a new treatment for uterine fibroids, which impact around two-thirds (66%) of women. The treatment is called linzagolix – sold as Yselty by Theramex – and is expected to
1
0
1